Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

memo - Magazine of European Medical Oncology

Issue 3/2018

Content (19 Articles)

editorial

Cure in metastatic disease

Hannes Kaufmann

editorial

Nonmalignant hematology

Paul N. Knoebl

editorial

Still making progress

Marija Balic

educational

Educational no. 2: flow cytometry

Katrin Hefler-Frischmuth

Open Access short review

Cure in metastatic breast cancer

Theresa Westphal, Simon Peter Gampenrieder, Gabriel Rinnerthaler, Richard Greil

short review

Cure in metastatic disease: how to manage and who is the right patient in GIST

Ursula Pluschnig

Open Access short review

Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?

Matthias Pinter, Wolfgang Sieghart

Open Access special report

Demystification of palliative care: what palliative care teams don’t want you to think about them

Eva K. Masel, Gudrun Kreye

comment

My burning issues in the management of liver metastases of advanced colorectal cancer

Peter Tschann, Stephanie Rauch, Paolo Girotti, Holger Rumpold, Ingmar Königsrainer

Open Access review

Current concepts and future directions in neoadjuvant chemotherapy of breast cancer

Rupert Bartsch, Elisabeth Bergen, Arik Galid

Open Access short review

SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy

Rupert Bartsch, Elisabeth Bergen

Open Access short review

SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis

Gabriel Rinnerthaler, Simon Peter Gampenrieder, Richard Greil

Open Access short review

Post SABCS local therapy and radiology

Florian Fitzal

Open Access short review

SABCS 2017 pathology: from bench to bedside

Zsuzsanna Bago-Horvath

Open Access review

Thrombotic thrombocytopenic purpura

Paul Knöbl

review

Role of complement in the pathogenesis of thrombotic microangiopathies

Eszter Trojnár, Ágnes Szilágyi, Bálint Mikes, Dorottya Csuka, György Sinkovits, Zoltán Prohászka

short review

Hemoglobinopathies—genetically diverse, clinically complex, and globally relevant

Holger Cario

Open Access short review

Current and evolving treatment strategies in adult immune thrombocytopenia

Jan-Paul Bohn, Michael Steurer

case report

Adenoid cystic carcinoma of the sublingual salivary gland obstructing the submandibular salivary gland duct

Ilson Sepulveda, J. Patricio Ulloa, M. Loreto Spencer, Paulo Vera, Francisco Rivas-Rodriguez, Ricardo Puentes

Aug 18
Issue: Special Issue 2/2018
Report from the ASCO 2018 Congress, Chicago, June 1st-5th, 2018
Nov 18
Issue: Special Issue 3/2018
Report from the WCLC 2018 Congress, Toronto, September 23rd–26th, 2018

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits